Drug metabolizing enzymes and transporters mRNA in peripheral blood mononuclear cells of healthy subjects: Biological variations and importance of pre-analytical steps

Current Drug Metabolism

Volumn 10, Issue 4, 2009, Pages 410-419

  Siest, Gérard ^a   Jeannesson, Elise ^a   Marteau, Jean Brice ^a   Samara, Anastasia ^a   Pfister, Michèle ^a   Visvikis Siest, Sophie ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; ALITRETINOIN; ALPRAZOLAM; ANGIOTENSIN II; BENZ[A]ANTHRACENE; CARBAZOLE DERIVATIVE; DIOXIN; DRUG METABOLIZING ENZYME; FENOFIBRATE; FORMYLINDOLOCARBAZOLE; INTERFERON; LIPOPOLYSACCHARIDE; MESSENGER RNA; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; POLYCYCLIC HYDROCARBON; RIFAMPICIN; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ANALYTIC METHOD; BIOLOGICAL RHYTHM; BODY MASS; DNA POLYMORPHISM; DRUG CLEARANCE; DRUG USE; FEEDING BEHAVIOR; HOUSEKEEPING GENE; HUMAN; OBESITY; PERIPHERAL BLOOD MONONUCLEAR CELL; REFERENCE VALUE; REVIEW; RNA TRANSPORT; SEX DIFFERENCE; TOBACCO;

BIOMARKERS, PHARMACOLOGICAL; CLINICAL CHEMISTRY TESTS; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LEUKOCYTES, MONONUCLEAR; MEMBRANE TRANSPORT PROTEINS; METABOLIC DETOXICATION, DRUG; REFERENCE VALUES; RESEARCH DESIGN; RNA, MESSENGER;

EID: 68349125163     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920009788498987     Document Type: Review

References (94)

1. Siest, G.; Jeannesson, E.; Marteau, J. B.; Samara, A.; Marie, B.; Pfister, M. and Visvikis-Siest, S. Transcription factor and drugmetabolizing enzyme gene expression in lymphocytes from healthy human subjects. Drug Metab. Dispos., 2008, 36(1), 182-189.
2. Visvikis-Siest, S.; Siest, G. The STANISLAS Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseases. Clin. Chem. Lab Med., 2008, 46(6), 733-747.
3. Gräsbeck, R.; Siest, G.; Wilding, P.; Williams, G.Z. and Whitehead, T.P. Provisional recommendation on the theory of reference values (1978). Part 1. The concept of reference values. Clin. Chem., 1979, 25(8), 1506-1508.
4. CLSI. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Proposed Guideline - Third Edition. CLSI document C28-P3. Wayne, P.A. Clinical and Laboratory Standards Institute, 2008.
5. Bonini, P.; Plebani, M.; Ceriotti, F.; Rubboli, F. Errors in laboratory medicine. Clin. Chem., 2002, 48(5), 691-8.
6. Visvikis-Siest, S.; Marteau, J. B.; Samara, A.; Berrahmoune, H.; Marie, B. and Pfister, M. Peripheral blood mononuclear cells (PBMCs): a possible model for studying cardiovascular biology systems Clin. Chem. Lab. Med., 2007, 45(9), 1154-1168.
7. Finnstrom, N.; Thorn, M.; Loof, L. and Rane, A. Independent patterns of cytochrome P450 gene expression in liver and blood in patients with suspected liver disease. Eur. J. Clin. Pharmacol., 2001, 57(5), 403-409.
8. Hannon-Fletcher, M. P., Barnett, Y. A. Lymphocyte cytochrome P450 expression: inducibility studies in male Wistar rats. Br. J. Biomed. Sci., 2008, 65(1), 1-6.
9. Rainen, L.; Oelmueller, U.; Jurgensen, S.; Wyrich, R.; Ballas, C.; Schram, J.; Herdman, C.; Bankaitis-Davis, D.; Nicholls, N.; Trollinger, D. and Tryon, V. Stabilization of mRNA expression in whole blood samples. Clin. Chem., 2002, 48(11), 1883-1890.
10. Marteau, J. B.; Mohr, S.; Pfister, M. and Visvikis-Siest, S. Collection and storage of human blood cells for mRNA expression profiling: a 15-month stability study. Clin. Chem., 2005, 51(7), 1250-1252.
11. Finnstrom, N.; Ask, B.; Dahl, M. L.; Gadd, M. and Rane, A. Intraindividual variation and sex differences in gene expression of cytochromes P450 in circulating leukocytes. Pharmacogenomics J., 2002, 2(2), 111-116.
12. Tuominen, R.; Warholm, M.; Moller, L. and Rannug, A. Constitutive CYP1B1 mRNA expression in human blood mononuclear cells in relation to gender, genotype, and environmental factors. Environ. Res., 2003, 93(2), 138-148.
13. Raucy, J. L.; Ingelman-Sundberg, M.; Carpenter, S.; Rannug, A.; Rane, A.; Franklin, M. and Romkes, M. Drug metabolizing enzymes in lymphocytes. J. Biochem. Mol. Toxicol., 1999, 13(3-4), 223-226.
14. Kuo, W. P.; Jenssen, T. K.; Butte, A. J.; Ohno-Machado, L. and Kohane, I. S. Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics, 2002, 18(3), 405-412.
15. Lee, J. K.; Bussey, K. J.; Gwadry, F. G.; Reinhold, W.; Riddick, G.; Pelletier, S. L.; Nishizuka, S.; Szakacs, G.; Annereau, J. P.; Shankavaram, U.; Lababidi, S.; Smith, L. H.; Gottesman, M. M. and Weinstein, J. N. Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI60 cancer cells. Genome. Biol., 2003, 4(12), R82.
16. Bas, A.; Forsberg, G.; Hammarstrom, S. and Hammarstrom, M. L. Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde- 3-phosphate-dehydrogenase for normalization in realtime quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes. Scand. J. Immunol., 2004, 59(6), 566-573.
17. Loseke, S.; Grage-Griebenow, E.; Wagner, A.; Gehlhar, K. and Bufe, A. Differential expression of IFN-alpha subtypes in human PBMC: evaluation of novel real-time PCR assays. J. Immunol. Methods, 2003, 276(1-2), 207-222.
18. Haas, C. E.; Brazeau, D.; Cloen, D.; Booker, B. M.; Frerichs, V.; Zaranek, C.; Frye, R. F. and Kufel, T. Cytochrome P450 mRNA expression in peripheral blood lymphocytes as a predictor of enzyme induction. Eur. J. Clin. Pharmacol., 2005, 61(8), 583-593.
19. Sterrenburg, E.; Turk, R.; Boer, J. M.; van Ommen, G. B. and den Dunnen, J. T. A common reference for cDNA microarray hybridizations. Nucleic Acids Res., 2002, 30(21), e116.
20. Park, P. J.; Cao, Y. A.; Lee, S. Y.; Kim, J. W.; Chang, M. S.; Hart, R. and Choi, S. Current issues for DNA microarrays: platform comparison, double linear amplification, and universal RNA reference. J. Biotechnol., 2004, 112(3), 225-245.
21. Sinues, B.; Fanlo, A.; Mayayo, E.; Carcas, C.; Vicente, J.; Arenaz, I. and Cebollada, A. CYP2A6 activity in a healthy Spanish population: effect of age, sex, smoking, and oral contraceptives. Hum. Exp. Toxicol., 2008, 27(5), 367-372.
22. Hukkanen, J.; Jacob, P. 3rd and Benowitz, N. L. Metabolism and disposition kinetics of nicotine. Pharmacol. Rev., 2005, 57(1): 79-115.
23. Stevens, J. C.; Marsh, S. A.; Zaya, M. J.; Regina, K. J.; Divakaran, K.; Le, M. and Hines, R. N. Developmental changes in human liver CYP2D6 expression. Drug Metab. Dispos., 2008, 36(8), 1587-1593.
24. Mangoni, A. A. The impact of advancing age on P-glycoprotein expression and activity: current knowledge and future directions. Expert Opin. Drug Metab. Toxicol., 2007, 3(3), 315-320.
25. Whitney, A. R.; Diehn, M.; Popper, S. J.; Alizadeh, A. A.; Boldrick, J. C.; Relman, D. A. and Brown, P. O. Individuality and variation in gene expression patterns in human blood. Proc. Natl. Acad. Sci. U.S.A, 2003, 100(4), 1896-1901.
26. Isensee, J.; Witt, H.; Pregla, R.; Hetzer, R.; Regitz-Zagrosek, V. and Ruiz, N. P. Sexually dimorphic gene expression in the heart of mice and men. J. Mol. Med., 2008, 86(1), 61-74.
27. Lin, P.; Hu, S. W. and Chang, T. H. Correlation between gene expression of aryl hydrocarbon receptor (AhR), hydrocarbon receptor nuclear translocator (Arnt), cytochromes P4501A1 (CYP1A1) and 1B1 (CYP1B1), and inducibility of CYP1A1 and CYP1B1 in human lymphocytes. Toxicol. Sci., 2003, 71(1), 20-26.
28. Lane, J. D.; Steege, J. F.; Rupp, S. L. and Kuhn, C. M. Menstrual cycle effects on caffeine elimination in the human female. Eur. J. Clin. Pharmacol., 1992, 43(5), 543-546.
29. Kashuba, A. D.; Bertino, J. S., Jr.; Rocci, M. L., Jr.; Kulawy, R. W.; Beck, D. J. and Nafziger, A. N. Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam. Clin. Pharmacol. Ther., 1998, 64(3), 269-277.
30. Dassi, C.; Signorini, S.; Gerthoux, P.; Cazzaniga, M. and Brambilla, P. Cytochrome P450 1B1 mRNA measured in blood mononuclear cells by quantitative reverse transcription-PCR. Clin. Chem., 1998, 44(12), 2416-2421.
31. Krovat, B. C.; Tracy, J. H. and Omiecinski, C. J. Fingerprinting of cytochrome P450 and microsomal epoxide hydrolase gene expression in human blood cells. Toxicol. Sci., 2000, 55(2), 352-360.
32. Smart, J., Daly, A. K. Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics, 2000, 10(1), 11-24.
33. Lind, A. B.; Wadelius, M.; Darj, E.; Finnstrom, N.; Lundgren, S. and Rane, A. Gene expression of cytochrome P450 1B1 and 2D6 in leukocytes in human pregnancy. Pharmacol. Toxicol., 2003, 92(6), 295-299.
34. Scandlyn, M. J.; Stuart, E. C. and Rosengren, R.J. Sex-specific differences in CYP450 isoforms in humans. Expert. Opin. Drug. Metab. Toxicol. 2008, 4(4), 413-424.
35. Lucas, D.; Farez, C.; Bardou, L.G.; Vaisse, J.; Attali, J.R. and Valensi, P. Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation. Fundam. Clin. Pharmacol., 1998, 12(5), 553-558.
36. Murray, M. Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis. Curr. Drug Metab, 2006, 7(1), 67-81.
37. Fontana, R. J.; Lown, K. S.; Paine, M. F.; Fortlage, L.; Santella, R. M.; Felton, J. S.; Knize, M. G.; Greenberg, A. and Watkins, P. B. Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers. Gastroenterology, 1999, 117(1), 89-98.
38. Boucher, P.; Seree, E.; Vidon, C.; de Souza, A. C.; Villard, P. H.; Chambon, R.; Barra, Y. and Vallon, J. J. Dietary lipids affect human ethanol-inducible CYP2E1 gene expression in vivo in mononuclear cells. Life Sci., 2000, 67(11), 1307-16.
39. Hu, S. W.; Lin, P. and Chen, C. C. Association of cytochrome P450 1B1 gene expression in peripheral leukocytes with blood lipid levels in waste incinerator workers. Ann. Epidemiol., 2008, 18(10), 784-791.
40. Clarke, M. W.; Burnett, J. R. and Croft, K. D. Vitamin E in human health and disease. Crit. Rev. Clin. Lab Sci., 2008, 45(5), 417-450.
41. Raucy, J. L.; Schultz, E. D.; Wester, M. R.; Arora, S.; Johnston, D. E.; Omdahl, J. L. and Carpenter, S. P. Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity. Drug Metab. Dispos., 1997, 25(12), 1429-1435.
42. Furukawa, M.; Nishimura, M.; Ogino, D.; Chiba, R.; Ikai, I.; Ueda, N.; Naito, S.; Kuribayashi, S.; Moustafa, M. A.; Uchida, T.; Sawada, H.; Kamataki, T.; Funae, Y. and Fukumoto, M. Cytochrome p450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver. Cancer Sci., 2004, 95(6), 520-529.
43. Liangpunsakul, S.; Kolwankar, D.; Pinto, A.; Gorski, J. C.; Hall, S. D. and Chalasani, N. Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with non-alcoholics. Hepatology, 2005, 41(5), 1144-1150.
44. Landi, M. T.; Bergen, A. W.; Baccarelli, A.; Patterson, D. G., Jr.; Grassman, J.; Ter-Minassian, M.; Mocarelli, P.; Caporaso, N.; Masten, S. A.; Pesatori, A. C.; Pittman, G. S. and Bell, D. A. Genetic variation and willingness to participate in epidemiologic research: data from three studies. Toxicology, 2005, 207(2), 191-202.
45. Gashaw, I.; Kirchheiner, J.; Goldammer, M.; Bauer, S.; Seidemann, J.; Zoller, K.; Mrozikiewicz, P. M.; Roots, I. and Brockmoller, J. Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics. Clin. Pharmacol. Ther., 2003, 74(5), 448-57.
46. Hitzl, M.; Drescher, S.; van der, K. H.; Schaffeler, E.; Fischer, J.; Schwab, M.; Eichelbaum, M. and Fromm, M. F. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics, 2001, 11(4), 293-298.
47. Owen, A.; Chandler, B.; Bray, P. G.; Ward, S. A.; Hart, C. A.; Back, D. J. and Khoo, S. H. Functional correlation of P-glycoprotein expression and genotype with expression of the human immunodeficiency virus type 1 coreceptor CXCR4. J. Virol., 2004, 78(21), 12022-12029.
48. Owen, A.; Chandler, B.; Back, D. J. and Khoo, S. H. Expression of pregnane-X-receptor transcript in peripheral blood mononuclear cells and correlation with MDR1 mRNA. Antivir. Ther., 2004, 9(5), 819-21.
49. Oselin, K.; Nowakowski-Gashaw, I.; Mrozikiewicz, P. M.; Wolbergs, D.; Pahkla, R. and Roots, I. Quantitative determination of MDR1 mRNA expression in peripheral blood lymphocytes: a possible role of genetic polymorphisms in the MDR1 gene. Eur. J. Clin. Invest, 2003, 33(3), 261-267.
50. Oselin, K.; Gerloff, T.; Mrozikiewicz, P. M.; Pahkla, R. and Roots, I. MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes. Fundam. Clin. Pharmacol., 2003, 17(4), 463-9.
51. la Porte, C. J.; Li, Y.; Beique, L.; Foster, B. C.; Chauhan, B.; Garber, G. E.; Cameron, D. W. and van Heeswijk, R. P. The effect of ABCB1 polymorphism on the pharmacokinetics of saquinavir alone and in combination with ritonavir. Clin. Pharmacol. Ther., 2007, 82(4), 389-95.
52. Markova, S.; Nakamura, T.; Sakaeda, T.; Makimoto, H.; Uchiyama, H.; Okamura, N. and Okumura, K. Genotype-dependent down-regulation of gene expression and function of MDR1 in human peripheral blood mononuclear cells under acute inflammation. Drug Metab. Pharmacokinet., 2006, 21(3), 194-200.
53. Fellay, J.; Marzolini, C.; Meaden, E. R.; Back, D. J.; Buclin, T.; Chave, J. P.; Decosterd, L. A.; Furrer, H.; Opravil, M.; Pantaleo, G.; Retelska, D.; Ruiz, L.; Schinkel, A. H.; Vernazza, P.; Eap, C. B. and Telenti, A. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet, 2002, 359(9300), 30-36.
54. Jamroziak, K.; Balcerczak, E.; Smolewski, P.; Robey, R. W.; Cebula, B.; Panczyk, M.; Kowalczyk, M.; Szmigielska-Kaplon, A.; Mirowski, M.; Bates, S. E. and Robak, T. MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia. Pharmacol. Rep., 2006, 58(5), 720-728.
55. Rebecchi, I. M.; Rodrigues, A. C.; Arazi, S. S.; Genvigir, F. D.; Willrich, M. A.; Hirata, M. H.; Soares, S. A.; Bertolami, M. C.; Faludi, A. A.; Bernik, M. M.; Dorea, E. L.; Dagli, M. L.; Avanzo, J. L. and Hirata, R. D. ABCB1 and ABCC1 expression in peripheral mononuclear cells is influenced by gene polymorphisms and atorvastatin treatment. Biochem. Pharmacol., 2009, 77(1), 66-75.
56. Carcillo, J. A.; Adedoyin, A.; Burckart, G. J.; Frye, R. F.; Venkataramanan, R.; Knoll, C.; Thummel, K.; Roskos, L.; Wilson, J. W.; Sereika, S.; Romkes, M.; Bebia, Z. and Branch, R. A. Coordinated intrahepatic and extrahepatic regulation of cytochrome p4502D6 in healthy subjects and in patients after liver transplantation. Clin. Pharmacol. Ther., 2003, 73(5), 456-467.
57. Nakamoto, T.; Hase, I.; Imaoka, S.; Hiroi, T.; Oda, Y.; Asada, A. and Funae, Y. Quantitative RT-PCR for CYP3A4 mRNA in human peripheral lymphocytes: induction of CYP3A4 in lymphocytes and in liver by rifampicin. Pharmacogenetics, 2000, 10(6), 571-575.
58. Starkel, P.; Sempoux, C.; Van, D. B., V; Stevens, M.; De, S. C.; Desager, J. P. and Horsmans, Y. CYP 3A proteins are expressed in human neutrophils and lymphocytes but are not induced by rifampicin. Life Sci., 1999, 64(8), 643-653.
59. Asghar, A.; Gorski, J. C.; Haehner-Daniels, B. and Hall, S. D. Induction of multidrug resistance-1 and cytochrome P450 mRNAs in human mononuclear cells by rifampin. Drug Metab. Dispos., 2002, 30(1), 20-26.
60. Landi, M. T.; Bertazzi, P. A.; Baccarelli, A.; Consonni, D.; Masten, S.; Lucier, G.; Mocarelli, P.; Needham, L.; Caporaso, N. and Grassman, J. TCDD-mediated alterations in the AhR-dependent pathway in Seveso, Italy, 20 years after the accident. Carcinogenesis, 2003, 24(4), 673-680.
61. Spencer, D. L.; Masten, S. A.; Lanier, K. M.; Yang, X.; Grassman, J. A.; Miller, C. R.; Sutter, T. R.; Lucier, G. W. and Walker, N. J. Quantitative analysis of constitutive and 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cytochrome P450 1B1 expression in human lymphocytes. Cancer Epidemiol. Biomarkers Prev., 1999, 8(2), 139-46.
62. Toide, K.; Yamazaki, H.; Nagashima, R.; Itoh, K.; Iwano, S.; Takahashi, Y.; Watanabe, S. and Kamataki, T. Aryl hydrocarbon hydroxylase represents CYP1B1, and not CYP1A1, in human freshly isolated white cells: trimodal distribution of Japanese population according to induction of CYP1B1 mRNA by environmental dioxins. Cancer Epidemiol. Biomarkers Prev., 2003, 12(3), 219-22.
63. Hanaoka, T.; Yamano, Y.; Pan, G.; Hara, K.; Ichiba, M.; Zhang, J.; Zhang, S.; Liu, T.; Li, L.; Takahashi, K.; Kagawa, J. and Tsugane, S. Cytochrome P450 1B1 mRNA levels in peripheral blood cells and exposure to polycyclic aromatic hydrocarbons in Chinese coke oven workers. Sci. Total. Environ. 2002, 296, 27-33
64. Hu, S. W.; Chen, C. C.; Kuo, C. Y.; Lin, W. H. and Lin, P. Increased cytochrome P4501B1 gene expression in peripheral leukocytes of municipal waste incinerator workers. Toxicol. Lett., 2006, 160, 112-120
65. Lampe, J. W.; Stepaniants, S. B.; Mao, M.; Radich, J. P.; Dai, H.; Linsley, P. S.; Friend, S. H. and Potter, J. D. Signatures of environmental exposures using peripheral leukocyte gene expression: tobacco smoke. Cancer Epidemiol.Biomarkers Prev., 2004, 13(3), 445-453.
66. Hannon-Fletcher, M. P.; O'Kane, M. J.; Moles, K. W.; Barnett, Y. A. and Barnett, C. R. Lymphocyte cytochrome P450-CYP2E1 expression in human IDDM subjects. Food Chem. Toxicol., 2001, 39(2), 125-32.
67. Wang, Z.; Hall, S. D.; Maya, J. F.; Li, L.; Asghar, A. and Gorski, J. C. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans. Br. J. Clin. Pharmacol., 2003, 55(1), 77-85.
68. Bernauer, U.; Garritsen, H.; Heinrich-Hirsch, B. and Gundert-Remy, U. Immunochemical analysis of cytochrome P450 variability in human leukapheresed samples and its consequences for the risk assessment process. Regul. Toxicol. Pharmacol., 2003, 37(2), 318-27.
69. Wibaut-Berlaimont, V.; Randi, A. M.; Mandryko, V.; Lunnon, M. W.; Haskard, D. O. and Naoumova, R. P. Atorvastatin affects leukocyte gene expression in dyslipidemia patients: in vivo regulation of hemostasis, inflammation and apoptosis. J. Thromb. Haemost., 2005, 3(4), 677-685.
70. Noshiro, M.; Usui, E.; Kawamoto, T.; Kubo, H.; Fujimoto, K.; Furukawa, M.; Honma, S.; Makishima, M.; Honma, K. and Kato, Y. Multiple mechanisms regulate circadian expression of the gene for cholesterol 7alpha-hydroxylase (Cyp7a), a key enzyme in hepatic bile acid biosynthesis. J. Biol. Rhythms, 2007, 22(4), 299-311.
71. Iber, H.; Li-Masters, T.; Chen, Q.; Yu, S. and Morgan, E. T. Regulation of hepatic cytochrome P450 2C11 via cAMP: implications for down-regulation in diabetes, fasting, and inflammation. J. Pharmacol. Exp. Ther., 2001, 297(1), 174-180.
72. Ueyama, J.; Nadai, M.; Zhao, Y. L.; Kanazawa, H.; Takagi, K.; Kondo, T.; Takagi, K.; Wakusawa, S.; Abe, F.; Saito, H.; Miyamoto, K. and Hasegawa, T. Effect of thalidomide on endotoxin-induced decreases in activity and expression of hepatic cytochrome P450 3A2. Biol. Pharm. Bull., 2008, 31(8), 1596-1600.
73. Zhou, S. F. Potential strategies for minimizing mechanism-based inhibition of cytochrome P450 3A4. Curr. Pharm. Des, 2008, 14(10), 990-1000.
74. Ioannides, C. Effect of diet and nutrition on the expression of cytochromes P450. Xenobiotica, 1999, 29(2), 109-54.
75. Le Marchand, L.; Franke, A. A.; Custer, L.; Wilkens, L. R. and Cooney, R. V. Lifestyle and nutritional correlates of cytochrome CYP1A2 activity: inverse associations with plasma lutein and alpha-tocopherol. Pharmacogenetics, 1997, 7(1), 11-9.
76. Ishibe, N.; Stampfer, M.; Hunter, D. J.; Hennekens, C. and Kelsey, K. T. A prospective study of cytochrome P450 1A1 polymorphisms and colorectal cancer risk in men. Cancer Epidemiol. Biomarkers Prev., 2000, 9(8), 855-856.
77. Baron, J. M.; Zwadlo-Klarwasser, G.; Jugert, F.; Hamann, W.; Rubben, A.; Mukhtar, H. and Merk, H. F. Cytochrome P450 1B1: a major P450 isoenzyme in human blood monocytes and macrophage subsets. Biochem. Pharmacol., 1998, 56(9), 1105-1110.
78. Ludescher, C.; Pall, G.; Irschick, E. U. and Gastl, G. Differential activity of P-glycoprotein in normal blood lymphocyte subsets. Br. J. Haematol., 1998, 101(4), 722-727.
79. Takeda, Y. Role of cardiovascular aldosterone in hypertension. Curr. Med. Chem. Cardiovasc. Hematol. Agents, 2005, 3(3), 261-266.
80. Nguyen, L. T.; Ramanathan, M.; Weinstock-Guttman, B.; Dole, K.; Miller, C.; Planter, M.; Patrick, K.; Brownscheidle, C. and Jacobs, L. D. Detection of cytochrome P450 and other drug-metabolizing enzyme mRNAs in peripheral blood mononuclear cells using DNA arrays. Drug Metab. Dispos., 2000, 28(8), 987-993.
81. Forcheron, F.; Cachefo, A.; Thevenon, S.; Pinteur, C. and Beylot, M. Mechanisms of the triglyceride- and cholesterol-lowering effect of fenofibrate in hyperlipidemic type 2 diabetic patients. Diabetes, 2002, 51(12), 3486-3491.
82. Meaden, E. R.; Hoggard, P. G.; Khoo, S. H. and Back, D. J. Determination of P-gp and MRP1 expression and function in peripheral blood mononuclear cells in vivo. J. Immunol. Methods, 2002, 262(1-2), 159-165.
83. Ruiz-Soto, R.; Richaud-Patin, Y.; Lopez-Karpovitch, X. and Llorente, L. Multidrug resistance-1 (MDR-1) in autoimmune disorders III: increased P-glycoprotein activity in lymphocytes from immune thrombocytopenic purpura patients. Exp. Hematol., 2003, 31(6), 483-487.
84. Kobayashi, H.; Takemura, Y.; Hayashi, T.; Ujiiye, T.; Kawase, M.; Niino, Y.; Miyachi, H.; Ohshima, T. and Hotta, T. Expression level of MDR1 message in peripheral blood leukocytes from healthy adults: a competitive nucleic acid sequence-based amplification assay for its determination. Clin. Chem. Lab Med., 2004, 42(10), 1098-1101.
85. Moustafa, M. A.; Ogino, D.; Nishimura, M.; Ueda, N.; Naito, S.; Furukawa, M.; Uchida, T.; Ikai, I.; Sawada, H. and Fukumoto, M. Comparative analysis of ATP-binding cassette (ABC) transporter gene expression levels in peripheral blood leukocytes and in liver with hepatocellular carcinoma. Cancer Sci., 2004, 95(6), 530-536.
86. Troost, J.; Albermann, N.; Emil, H. W. and Weiss, J. Cholesterol modulates P-glycoprotein activity in human peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun., 2004, 316(3), 705-11.
87. Yamamoto, J.; Ihara, K.; Nakayama, H.; Hikino, S.; Satoh, K.; Kubo, N.; Iida, T.; Fujii, Y. and Hara T. Characteristic expression of aryl hydrocarbon receptor repressor gene in human tissues: organ-specific distribution and variable induction patterns in mononuclear cells. Life Sci., 2004, 74(8), 1039-1049.
88. Langmann, T.; Mauerer, R. and Schmitz, G. Human ATP-binding cassette transporter TaqMan low-density array: analysis of macrophage differentiation and foam cell formation. Clin.Chem., 2006, 52(2), 310-313.
89. Miura, R.; Nakamura, K.; Miura, D.; Miura, A.; Hisamatsu, K.; Kajiya, M.; Hashimoto, K.; Nagase, S.; Morita, H.; Fukushima Kusano, K.; Emori, T.; Ishihara, K. and Ohe, T. Aldosterone synthesis and cytokine production in human peripheral blood mononuclear cells. J. Pharmacol. Sci., 2006, 102(3), 288-295.
90. Storch, C. H.; Klimm, H. D.; Heinrich, T.; Haefeli, W. E. and Weiss, J. Plasma LDL cholesterol has no impact on P-glycoprotein (MDR1/ABCB1) activity in human peripheral blood mononuclear cells. Naunyn Schmiedebergs Arch. Pharmacol., 2007, 376(1-2), 135-143.
91. Giorelli, M.; Livrea, P.; Minervini, M. G. and Trojano, M. Immunomodulatory properties of increased levels of liver X receptor beta in peripheral blood mononuclear cells from multiple sclerosis patients. Exp. Neurol., 2007, 204(2), 759-766.
92. Storch, C. H.; Nikendei, C.; Schild, S.; Haefeli, W. E.; Weiss, J. and Herzog, W. Expression and activity of P-glycoprotein (MDR1/ABCB1) in peripheral blood mononuclear cells from patients with anorexia nervosa compared with healthy controls. Int. J. Eat. Disord., 2008, 41(5), 432-8.
93. Turriziani, O.; Gianotti, N.; Falasca, F.; Boni, A.; Vestri, A. R.; Zoccoli, A.; Lazzarin, A. and Antonelli, G. Expression levels of MDR1, MRP1, MRP4, and MRP5 in peripheral blood mononuclear cells from HIV infected patients failing antiretroviral therapy. J. Med. Virol., 2008, 80(5), 766-71.
94. Zhou, H.; Tan, K. C.; Shiu, S. W. and Wong, Y. Determinants of leukocyte adenosine triphosphate-binding cassette transporter G1 gene expression in type 2 diabetes mellitus. Metabolism, 2008, 57(8), 1135-40.